ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION
ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION
批准号:
6639641
负责人:
BALARAMAN KALYANARAMAN
金额:
$26.16万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-10 至 2004-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this proposed research is to understand the
role of ROS and RNS in the onset of age-related neurodegenerative diseases. The
general hypothesis to be tested is that nNOS can generate both superoxide and
nitric oxide in a ratio that is regulated by flavin cofactors, redox active
compounds, L-arginine and tetrahydrobiopterin (BH4). The specific hypothesis to
be tested is that nNOS plays a crucial role in the neurotoxicity of MPP+, a
mitochondrial neurotoxin that induces Parkinsonian symptoms. Specific aims: 1)
the kinetic of superoxide and NO formation from purified nNOS in the presence
and absence of MPP+ will be determined. 2) The role of nNOS in the cytotoxic
and apoptotic effects of MPP+ in neuronal cells will be determined. Similar
experiments will be determined in BH4-deficient neuronal cells that do not
synthesize NO. In these systems, ROS and RNS formation will be measured. 3) The
effect of MPP+ toxicity and apoptosis in neuronal cells isolated from nNOS
knockout mice will be determined. Methods: Extracellular generation of
superoxide will be measured by spin-trapping and intracellular formation of
superoxide will be determined by monitoring mitochondrial aconitase activity.
Aconitase carbonyls and nitrated protein will be determined by immunochemical
methods. significance results from this study should provide new mechanistic
insight into ROS and RNS formation from nNOS. Neuronal NOS has been implicated
in the onset of several age-related neurodegeneration disorder including
Parkinson's, Huntington's, and Lou Gehrig's diseases. Inhibition of nNOS and
scavenger of ROS have been shown to exert neuroprotection in animal model
mimicking these pathologies. New therapeutic strategies for treating
age-associated neurodegenerative diseases may emerge from these studies.
Novelty: Novel aspect of this proposal is the ability to measure simultaneously
both NO and superoxide from purified nNOS in response to MPP+ and other
co-factors. The superoxide-mediated oxidation of 4Fe-4S clusters in aconitase
inactivates the enzyme and increases oxidative stress. The availability of
novel superoxide dismutase mimetics has made it possible to prove more
thoroughly regarding the nature of ROS causing the inactivation of aconitase in
the intracellular milieu.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:9763831
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:9915863
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10489835
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10687020
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10476701
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
-
批准号:10497449
-
项目类别:
-
资助金额:$52.37万
-
财政年份:2017
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer with mitochondria-targeted honokiol
-
批准号:10092125
-
项目类别:
-
资助金额:$11.51万
-
财政年份:2017
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8453421
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
EPR 2010
-
批准号:7912542
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8271285
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8089425
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7531598
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7934163
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8074198
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8268535
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8077923
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7645854
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7849003
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Peroxide, NO and Iron Signaling in Endothelial Damage
-
批准号:6850673
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Peroxide, NO and Iron Signaling in Endothelial Damage
-
批准号:6600276
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2003
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: